Medtronic (MDT) announced the broad U.S. commercial launch of the MiniMed 780G system integrated with the Instinct sensor, made by Abbott and designed exclusively for MiniMed systems. Following U.S. FDA clearance of the system earlier this year to enable integration with the Instinct sensor, the system is now shipping to customers across the U.S., marking a major milestone in diabetes technology and delivering a smart, seamless way to manage diabetes.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MDT:
- Teva, Amgen, Rithm, Fastly, Medtronic: Major Stock Moves!
- QuantumScape, Medtronic, MP Materials, Canadian Solar, AeroVironment: Trending by Analysts
- Medtronic price target raised to $110 from $103 at Truist
- Medtronic price target raised to $111 from $109 at Barclays
- DoorDash, Baidu upgraded: Wall Street’s top analyst calls